A growing number of employers are offering weight loss drugs as part of their healthcare plans, while still promoting holistic programs and lifestyle changes as a long-term solution to physical ...
The list of drugs seeing a price cut for Medicare recipients is increasing — some cancer meds are set to drop by thousands.
Starting Jan. 1, 2026, Pennsylvania will limit GLP‑1 weight‑loss drugs under Medicaid — threatening access for thousands of ...
Nov 21 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss ...
(Reuters) -Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access to its blockbuster weight-loss drug through partnerships with ...
Everyday Health on MSN
New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight
The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...
Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...
The world’s first GLP-1 weight loss treatment is being administered for pets on an experimental basis. The first cat was ...
According to a press release, the duodenal switch procedure is a type of surgery "that combines stomach reduction with ...
Smithsonian Magazine on MSN
Can GLP-1s Help Fat Cats Lose Weight? The First Clinical Trial Testing the Drugs for Weight Loss in Felines Has Begun
San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback